Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Fabry's disease; towards a treatment].

G E Linthorst1, C E Hollak, D K Bosman

  • 1Afd. Inwendige Geneeskunde, onderafd. Klinische Hematologie, Academisch Medisch Centrum, Meibergdreef 9, 1105 AZ Amsterdam. g.e.linthorst@amc.uva.nl

Nederlands Tijdschrift Voor Geneeskunde
|January 6, 2001
PubMed
Summary

Fabry's disease is an X-linked disorder caused by alpha-galactosidase A deficiency. An atypical cardiac-only presentation suggests higher patient numbers than predicted, necessitating improved diagnostics and future therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Navigating the digital landscape: challenges and advancements in fostering a one health approach through humanity-centered design in mobile health.

One health (Amsterdam, Netherlands)·2025
Same author

[Is faster diagnosis of rare diseases feasible?]

Nederlands tijdschrift voor geneeskunde·2020
Same author

Congenital methaemoglobinaemia in a 61-year-old patient with normal haemoglobin levels.

The Netherlands journal of medicine·2018
Same author

Hearing loss in children with Fabry disease.

Journal of inherited metabolic disease·2017
Same author

Simultaneous quantitation of sphingoid bases by UPLC-ESI-MS/MS with identical <sup>13</sup>C-encoded internal standards.

Clinica chimica acta; international journal of clinical chemistry·2017
Same author

Very Long-Chain Acyl-Coenzyme A Dehydrogenase Deficiency and Perioperative Management in Adult Patients.

JIMD reports·2016

Area of Science:

  • Biochemistry
  • Genetics
  • Rare Diseases

Context:

  • Fabry disease is an X-linked lysosomal storage disorder.
  • Caused by alpha-galactosidase A enzyme deficiency.
  • Glycolipid deposition leads to multi-organ complications.

Purpose:

  • To discuss the clinical presentation and diagnosis of Fabry disease.
  • To highlight atypical cardiac manifestations.
  • To suggest potential future treatments.

Summary:

  • Fabry disease results from alpha-galactosidase A deficiency, leading to glycolipid accumulation.
  • Symptoms include skin, eye, neurological, renal, and cardiovascular issues.
  • Atypical cardiac-only presentations may increase the estimated patient population.

Related Experiment Videos

Impact:

  • Highlights the need for broader diagnostic considerations for Fabry disease.
  • Suggests enzyme replacement or substrate reduction therapies as future treatment options.
  • Emphasizes the potential underdiagnosis due to atypical presentations.